Maryland Takes Step Toward Capping Drug Prices
Governor is poised to sign bill creating panel to review expensive prescription drugs and limit how much agencies will pay for them
The Wall Street Journal
April 30, 2019
Maryland is poised to become the first state to create a panel to review expensive prescription drugs and cap how much public agencies will pay for them.
The new legislation creates a five-person board tasked with identifying drugs that may be too expensive for patients or governments, and then submitting an analysis and recommendations to the legislature. The board could begin setting payment caps in 2022.
